Methyl(3s,4s)-4-methylpiperidine-3-carboxylate;hydrochloride, 98%, 250mg

1-(2-BROMO-5-METHYLPHENYL)ETHANONE, 95.0%, 250mg

Ethyl 3-(hydroxymethyl)-1H-pyrrole-2-carboxylate, 98%, 250mg

2-Hexanol>98.0%(GC)100mL

(R)-8-Fluorochroman-4-amine hydrochloride, 95.0%, 1g

N-Methyl-1,1,1-trifluoro-2-propylamine, 99.0%, 25g

2-Ethyl-4-methyl-1H-imidazole-5-carbaldehyde, 97.0%, 5g

5,6,7,8-TETRAHYDRO-2-(4-METHYLPHENYL)-IMIDAZO[2,1-B]BENZOTHIAZOLE HYDROBROMIDE, 95.0%, 1g

(R)-3-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid, 95+%, 250mg

Tubes d'élution ROTI® MEGA, 14 kDa, 1 pièce(s), 15 ml

4-(3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide, 95.0%, 250mg

TERT-BUTYL (3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PROPYL)CARBAMATE, 95%, 250mg

Acetanilida, 98,5%, para síntesis, 2,5 kg, envase plástico.